Lördag 8 November | 16:55:49 Europe / Stockholm

Svenska | English

Gubra

Filter

År

Typ

Språk

Rensa

2025-11-07 18:03:00 Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares

2025-11-07 07:30:00 Trading statement Q3-2025: Expanding our R&D activities 380,00 DKK | +1,93% | 19,2 MDKK

2025-11-06 17:16:00 Record earnings for Gubra; revised outlook for the CRO business 380,00 DKK | +1,93% | 19,2 MDKK

2025-09-02 07:30:00 Gubra Announces Completion of Solar & Battery Park 389,60 DKK | -2,26% | 8,37 MDKK

2025-08-21 07:30:00 Interim report H1 2025: Group revenue and earnings record-high 370,00 DKK | +4,34% | 52,7 MDKK

2025-08-20 17:11:00 Record quarter for Gubra, but revised outlook for the CRO business 370,00 DKK | +4,34% | 52,7 MDKK

2025-08-12 10:42:00 Markus Rohrwild appointed new CEO of Gubra in a planned succession process 348,80 DKK | +1,99% | 6,02 MDKK

2025-07-10 22:14:00 Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares 414,80 DKK | -0,77% | 11,1 MDKK

2025-07-10 22:07:00 Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares 414,80 DKK | -0,77% | 11,1 MDKK

2025-06-30 09:51:00 Gubra shares are traded ex-dividend 465,20 DKK | -11,56% | 42,0 MDKK

2025-06-27 13:09:00 COURSE OF GUBRA A/S' EXTRAORDINARY GENERAL MEETING REGARDING EXTRAORDINARY DIVIDEND 526,00 DKK | +2,43% | 63,7 MDKK

2025-06-03 07:30:00 NOTICE TO CONVENE EXTRAORDINARY GENERAL MEETING REGARDING EXTRAORDINARY DIVIDEND 450,80 DKK | +14,18% | 121 MDKK

2025-05-09 07:30:00 Trading statement Q1-2025: A landmark deal for GUBamy 398,80 DKK | +3,58% | 10,7 MDKK

2025-04-03 16:17:00 Gubra Welcomes New Board Members at 2025 AGM 416,00 DKK | -2,80% | 39,1 MDKK

2025-04-03 14:06:00 Course of Gubra A/S' Annual General Meeting 2025 416,00 DKK | -2,80% | 39,1 MDKK

2025-04-01 16:52:00 Successful Transaction Closure of License Agreement 448,00 DKK | +8,21% | 74,0 MDKK

2025-04-01 08:45:00 Gubra announces positive GUBamy Phase 1 interim MAD results 448,00 DKK | +8,21% | 74,0 MDKK

2025-03-28 22:32:00 Regulatory Condition Satisfied for License Agreement between AbbVie and Gubra

2025-03-10 12:57:00 NOTICE TO CONVENE ANNUAL GENERAL MEETING 2025 465,00 DKK | -9,18% | 55,5 MDKK

2025-03-03 07:08:00 AbbVie and Gubra Announce License Agreement to Develop an Amylin Analog for the Treatment of Obesity 650,00 DKK | +15,25% | 198 MDKK

2025-02-28 07:30:00 Annual Report 2024: Excellent performance across Gubra 564,00 DKK | -12,42% | 187 MDKK

2025-01-15 07:30:00 Gubra appoints new Chief Operating Officer 670,00 DKK | +0,90% | 7,93 MDKK

2024-12-30 13:30:00 Gubra Announces New Collaboration with Amylyx Pharmaceuticals to Develop a Novel Long-acting GLP-1 Receptor Antagonist 624,00 DKK | -0,95% | 29,4 MDKK

2024-11-13 18:36:00 Gubra announces positive GUBamy Phase 1 SAD data (correction) 686,00 DKK | +43,51% | 224 MDKK

2024-11-13 17:41:00 Gubra announces positive GUBamy Phase 1 SAD data 686,00 DKK | +43,51% | 224 MDKK

2024-11-07 07:30:00 Trading statement Q3-2024: Another strong quarter 425,00 DKK | -1,39% | 19,6 MDKK

2024-10-31 11:07:00 Gubra announces discontinuation of development of NYP2 in obesity with Boehringer Ingelheim 430,00 DKK | -4,02% | 69,2 MDKK

2024-09-06 21:42:00 Major shareholder announcement

2024-08-22 07:30:00 Interim report H1 2024: Strong performance across Gubra 620,00 DKK | +1,31% | 78,0 MDKK

2024-08-21 17:12:00 Gubra raises financial outlook for 2024 620,00 DKK | +1,31% | 78,0 MDKK

2024-07-10 23:38:00 Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares 628,00 DKK | +14,18% | 140 MDKK

2024-07-02 20:25:00 Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares 590,00 DKK | +4,24% | 52,7 MDKK

2024-07-01 07:30:00 Boehringer Ingelheim and Gubra announce start of clinical development of a potential first-in-class, triple agonist, obesity treatment 602,00 DKK | +23,11% | 119 MDKK

2024-06-28 12:05:00 Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares 489,00 DKK | +6,30% | 35,7 MDKK

2024-06-04 15:30:00 Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares 326,00 DKK | -0,61% | 6,72 MDKK

2024-06-04 15:25:00 Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares 326,00 DKK | -0,61% | 6,72 MDKK

2024-05-07 07:30:00 Trading statement Q1-2024: Strong start to the year 348,00 DKK | +12,62% | 66,8 MDKK

2024-05-06 17:15:00 Gubra raises financial outlook for 2024 348,00 DKK | +12,62% | 66,8 MDKK

2024-04-17 07:30:00 Gubra unveils UCN2 as novel anti-obesity drug candidate for healthy weight loss 304,00 DKK | +8,96% | 25,7 MDKK

2024-04-04 12:32:00 RESOLUTIONS OF GUBRA A/S' ANNUAL GENERAL MEETING 2024 299,00 DKK | +0,67% | 12,9 MDKK

2024-04-03 21:45:00 Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares 299,00 DKK | +0,67% | 12,9 MDKK

2024-04-03 21:35:00 Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares 299,00 DKK | +0,67% | 12,9 MDKK

2024-03-27 14:45:00 Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares 291,00 DKK | +11,92% | 35,8 MDKK

2024-03-26 22:45:00 Major shareholder announcement: The Capital Group Companies Inc. 291,00 DKK | +11,92% | 35,8 MDKK

2024-03-25 11:29:00 Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares 281,00 DKK | -6,33% | 182 MDKK

2024-03-25 09:56:00 Major shareholder announcement 281,00 DKK | -6,33% | 182 MDKK

2024-03-06 09:00:00 NOTICE TO CONVENE ANNUAL GENERAL MEETING 2024 221,00 DKK | +0,45% | 12,1 MDKK

2024-03-04 21:41:00 Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares 220,00 DKK | +4,76% | 22,6 MDKK

Visa fler

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Gubra

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden